Cargando…

Serologic Response and Safety after a Third Dose of the COVID-19 BNT162b2 Vaccine in Patients with Inflammatory Bowel Diseases

Vaccines are pivotal for control of the coronavirus disease (COVID-19) pandemic. Patients with inflammatory bowel diseases (IBDs) treated with antitumor necrosis factor (TNF)-α have lower serologic response after two COVID-19 vaccine doses. Data regarding a third vaccine dose are scarce. An Israeli...

Descripción completa

Detalles Bibliográficos
Autores principales:	Edelman-Klapper, Hadar, Rabinowitz, Keren Masha, Zittan, Eran, Shitrit, Ariella Bar-Gil, Goren, Idan, Avni-Biron, Irit, Ollech, Jacob E., Lichtenstein, Lev, Banai-Eran, Hagar, Yanai, Henit, Snir, Yifat, Pauker, Maor H., Friedenberg, Adi, Levy-Barda, Adva, Broitman, Yelena, Ben Zvi, Haim, Perets, Tsachi-Tsadok, Eliakim, Rami, Barkan, Revital, Goren, Sophy, Cohen, Dani, Dotan, Iris
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10386081/ https://www.ncbi.nlm.nih.gov/pubmed/37515078 http://dx.doi.org/10.3390/vaccines11071263

Ejemplares similares

Lower Serologic Response to COVID-19 mRNA Vaccine in Patients With Inflammatory Bowel Diseases Treated With Anti-TNFα
por: Edelman-Klapper, Hadar, et al.
Publicado: (2022)

Su1488: WITHIN 6 MONTHS FROM COVID-19 BNT162B2 VACCINE PATIENTS WITH INFLAMMATORY BOWEL DISEASES TREATED WITH ANTI-TNFα HAVE SIGNIFICANTLY LOWER SEROLOGIC RESPONSES
por: Rabinowitz, Keren M., et al.
Publicado: (2022)

A Real-World Prospective Cohort Study of Patients With Newly Diagnosed Crohn’s Disease Treated by a Multidisciplinary Team: 1-Year Outcomes
por: Yanai, Henit, et al.
Publicado: (2023)

Anti-TNFα Treatment Impairs Long-Term Immune Responses to COVID-19 mRNA Vaccine in Patients with Inflammatory Bowel Diseases
por: Rabinowitz, Keren Masha, et al.
Publicado: (2022)

Clinical approach to skin eruptions induced by anti-TNF agents among patients with inflammatory bowel diseases: insights from a multidisciplinary IBD-DERMA clinic
por: Yanai, Henit, et al.
Publicado: (2021)

Pregnancy Outcomes in a Cohort of Patients with Inflammatory Bowel Disease: Data from a Multidisciplinary Clinic in a Tertiary Center
por: Avni Biron, Irit, et al.
Publicado: (2023)

Risk of consecutive immunogenic failure in switchers of anti-tumor necrosis factor alpha among patients with inflammatory bowel diseases
por: Yanai, Henit, et al.
Publicado: (2022)

SARS-CoV-2 IgG Antibody Levels in Women with IBD Vaccinated during Pregnancy
por: Avni Biron, Irit, et al.
Publicado: (2022)

Vedolizumab Is Associated with Longer Drug Sustainability Compared to Infliximab in Moderate-to-Severe Ulcerative Colitis: Long-Term Real-World Cohort Data
por: Konikoff, Tom, et al.
Publicado: (2023)

Increasing adherence to the Mediterranean diet and lifestyle is associated with reduced fecal calprotectin and intra-individual changes in microbial composition of healthy subjects
por: Godny, L., et al.
Publicado: (2022)

COVID-19 in Patients with Inflammatory Bowel Disease: The Israeli Experience
por: Lichtenstein, Lev, et al.
Publicado: (2022)

Effect of the transcutaneous electrical stimulation system on esophageal-acid exposure in patients non-responsive to once-daily proton-pump inhibitor: proof-of-concept study
por: Dickman, Ram, et al.
Publicado: (2021)

Correlation between Quantitative (13)C-Urea Breath Test and Helicobacter pylori Treatment Success in a Population-Based Cohort
por: Boltin, Doron, et al.
Publicado: (2018)

Newly Diagnosed Crohn’s Disease Patients in India and Israel Display Distinct Presentations and Serological Markers: Insights from Prospective Cohorts
por: Goren, Idan, et al.
Publicado: (2022)

Rifaximin for small intestinal bacterial overgrowth in patients without irritable bowel syndrome
por: Boltin, Doron, et al.
Publicado: (2014)

Human intestinal epithelial cells can internalize luminal fungi via LC3-associated phagocytosis
por: Cohen-Kedar, Sarit, et al.
Publicado: (2023)

Advanced technology for assessment of endoscopic and histological activity in ulcerative colitis: a systematic review and meta-analysis
por: Nardone, Olga Maria, et al.
Publicado: (2022)

The New Proactive Approach and Precision Medicine in Crohn’s Disease
por: Zittan, Eran, et al.
Publicado: (2020)

Intestinal Fatty Acid Binding Protein Levels in Pediatric Celiac Patients in Transition From Active Disease to Clinical and Serological Remission
por: Hoofien, Assaf, et al.
Publicado: (2021)

Sex differences in urea breath test results for the diagnosis of Helicobacter pylori infection: a large cross-sectional study
por: Eisdorfer, Ido, et al.
Publicado: (2018)

Comparison of Short- and Long-Term Effectiveness between Anti-TNF and Ustekinumab after Vedolizumab Failure as First-Line Therapy in Crohn’s Disease: A Multi-Center Retrospective Cohort Study
por: Albshesh, Ahmad, et al.
Publicado: (2023)

Incidence and risk factors for intussusception among children in northern Israel from 1992 to 2009: a retrospective study
por: Muhsen, Khitam, et al.
Publicado: (2014)

Relationships of H. pylori infection and its related gastroduodenal morbidity with metabolic syndrome: a large cross-sectional study
por: Refaeli, Rotem, et al.
Publicado: (2018)

Associations of Helicobacter pylori infection and peptic disease with diabetic mellitus: Results from a large population-based study
por: Haj, Saeda, et al.
Publicado: (2017)

Preoperative Exclusive Total Parental Nutrition is Associated with Clinical and Laboratory Remission in Severe Active Crohn’s Disease—A Pilot Study
por: Zittan, Eran, et al.
Publicado: (2020)

Differences in glycated hemoglobin levels and cholesterol levels in individuals with diabetes according to Helicobacter pylori infection
por: Haj, Saeda, et al.
Publicado: (2021)

Pentraxin 3 and Shigella LPS and IpaB Antibodies Interplay to Defeat Shigellosis
por: Meron-Sudai, Shiri, et al.
Publicado: (2022)

Fecal calprotectin correlates with active colonic inflammatory bowel disease but not with small intestinal Crohn's disease activity
por: Zittan, Eran, et al.
Publicado: (2018)

Development and validation of novel algorithms to identify patients with inflammatory bowel diseases in Israel: an epi-IIRN group study
por: Friedman, Mira Y, et al.
Publicado: (2018)

Convulsions in children hospitalized for acute gastroenteritis
por: Iflah, Moti, et al.
Publicado: (2021)

Post-Induction High Adalimumab Drug Levels Predict Biological Remission at Week 24 in Patients With Crohn's Disease
por: Zittan, Eran, et al.
Publicado: (2021)

Perceptual Anchoring in Preschool Children: Not Adultlike, but There
por: Banai, Karen, et al.
Publicado: (2011)

Enhanced Humoral Immune Responses against Toxin A and B of Clostridium difficile is Associated with a Milder Disease Manifestation
por: Na’amnih, Wasef, et al.
Publicado: (2020)

Cell-centred meta-analysis reveals baseline predictors of anti-TNFα non-response in biopsy and blood of patients with IBD
por: Gaujoux, Renaud, et al.
Publicado: (2019)

Autoimmune Pancreatitis in Patients with Inflammatory Bowel Disease: A Real-World Multicentre Collaborative ECCO CONFER Study
por: Eder, Piotr, et al.
Publicado: (2023)

Correlates of gastroenterology health-services utilization among patients with gastroesophageal reflux disease: a large database analysis
por: Na’amnih, Wasef, et al.
Publicado: (2019)

RTVP-1 regulates glioma cell migration and invasion via interaction with N-WASP and hnRNPK
por: Ziv-Av, Amotz, et al.
Publicado: (2015)

In Response to ”Comment on Average Volume-Assured Pressure Support Modes for Hypercapnic Respiratory Failure its early use in the Emergency Department”
por: Gören, Nurfer
Publicado: (2022)

Intronic Alus Influence Alternative Splicing
por: Lev-Maor, Galit, et al.
Publicado: (2008)

Magnetic resonance enterography or video capsule endoscopy – what do Crohn’s disease patients prefer?
por: Lahat, Adi, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_5869h90vvo1b0jkmu83hun8134